Main Profile

At A Glance

MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine

Dr. Aurora discusses her paper, which To evaluates the efficacy and tolerability of MAP0004 compared with placebo for a single migraine in adult migraineurs
Length: 06:31

Contact

Questions about MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine

Want more info about MAP0004, Orally Inhaled DHE: A Randomized, Controlled Study in the Acute Treatment of Migraine? Get free advice from education experts and Noodle community members.

  • Answer

Ask a New Question